Inventor
FORSSMANN WOLF-GEORG
DE39 patents
⚠️ This page may combine multiple inventors who share the name “FORSSMANN WOLF-GEORG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PHARIS BIOTEC GMBH
8 patentsUS6326163B1Dec 4, 2001
Method for the direct diagnostic detection of genetically caused pathogenic point mutations
PHARIS BIOTEC GMBH31 citations88
US7033997B2Apr 25, 2006
Use of natriuretic peptides as antibiotically active substances for the treatment of bacterial infections
PHARIS BIOTEC GMBH33 citations87
US6831064B1Dec 14, 2004
Use of urodilatin for treating chronic kidney failure with residual kidney functions
PHARIS BIOTEC GMBH14 citations81
US6849593B1Feb 1, 2005
Bifidogenic peptides
PHARIS BIOTEC GMBH8 citations67
US6939851B1Sep 6, 2005
Serine proteinase inhibitors
PHARIS BIOTEC GMBH2 citations54
US10294272B2May 21, 2019
Peptides with antagonistic activities against natural CXCR4
PHARIS BIOTEC GMBH0 citations46
US10125169B2Nov 13, 2018
Protransduzin B, a gene transfer enhancer
PHARIS BIOTEC GMBH0 citations46
US7045594B1May 16, 2006
Serine proteinase inhibitors
PHARIS BIOTEC GMBH1 citations41
FORSSMANN WOLF-GEORG
5 patentsUS9045563B2Jun 2, 2015
CXC chemokine receptor 4 (CXCR4) antagonistic polypeptide
FORSSMANN WOLF-GEORG4 citations67
US8106061B2Jan 31, 2012
Use of phosphodiesterase inhibitors in the treatment of prostatic diseases
FORSSMANN WOLF-GEORG4 citations53
US9434780B2Sep 6, 2016
Process for preparing human relaxin-2
FORSSMANN WOLF-GEORG2 citations52
US8293711B2Oct 23, 2012
Use of natriuretic peptides for treating angioedema syndromes
FORSSMANN WOLF-GEORG0 citations52
US8791124B2Jul 29, 2014
Use of phosphordiesterase inhibitors in the treatment of prostatic diseases
FORSSMANN WOLF-GEORG0 citations42
FORSSMANN WOLF GEORG
4 patentsUS5891904AApr 6, 1999
Use of inhibitors of phosphodiesterase IV
FORSSMANN WOLF GEORG26 citations89
US6083483AJul 4, 2000
Inhibitors of phosphodiesterase IV for x-ray imaging
FORSSMANN WOLF GEORG6 citations70
US6403553B1Jun 11, 2002
Use of polypeptides for treating thrombocytopenia
FORSSMANN WOLF GEORG9 citations69
US6180773B1Jan 30, 2001
Tandem cDNAs encoding chemokines CC-1, CC-2, and CC-3
FORSSMANN WOLF GEORG9 citations67
HAEMOPEP PHARMA GMBH
4 patentsUS5744444AApr 28, 1998
HPTH-fragment-(1-37), the preparation thereof, medicaments containing same and the use thereof
HAEMOPEP PHARMA GMBH35 citations89
US5571789ANov 5, 1996
Use of urodilatin in pulmonary and bronchial diseases
HAEMOPEP PHARMA GMBH20 citations86
US5665861ASep 9, 1997
Cardiodilatin fragment, process for preparing same and use thereof
HAEMOPEP PHARMA GMBH15 citations78
US6579849B2Jun 17, 2003
Antibiotic peptides from bovine milk
HAEMOPEP PHARMA GMBH4 citations57
IPF PHARMACEUTICALS GMBH
3 patentsUS7037896B1May 2, 2006
Peptide (VIRIP) which inhibits a circulating virus in humans and the use thereof
IPF PHARMACEUTICALS GMBH8 citations70
US7741287B2Jun 22, 2010
Peptides for the treatment of herpes virus infections
IPF PHARMACEUTICALS GMBH0 citations48
US7232796B2Jun 19, 2007
Medicament containing a tissue inhibitor of metalloproteinases-2 (TIMP-2) as an osteoanabolically active substance
IPF PHARMACEUTICALS GMBH0 citations30